Latest Rofecoxib Stories
The primary purpose of a 1999 clinical study that Merck & Co Inc said was done to test side effects of Vioxx, was actually to support a marketing campaign before the now-withdrawn painkiller's launch, according to U.S. researchers.
A new study asserts that a 1999 Vioxx clinical drug trial sponsored by Merck & Co. was done to support a marketing campaign, U.S. researchers said. "You hear people talk about it, but I've never seen anyone ...
By Januzzi, James L Jr In May 1999, the US Food and Drug Administration approved rofecoxib, the first nonsteroidal antiinflammatory drug (NSAID)1 with specific cyclooxygenase II (COX-II) activity. Soon to follow were the approvals of other COX-II inhibitors, including celecoxib.
By Brune, Kay Katus, Hugo A; Moecks, Joachim; Spanuth, Eberhard; Jaffe, Allan S; Giannitsis, Evangelos BACKGROUND: We investigated whether higher concentrations of N- terminal pro-B-type natriuretic peptide (NT-proBNP) predicts cardiovascular adverse events (CV-AEs) in patients with osteoarthritis treated with antiinflammatory drugs.
By Phil Kabler Prescription data mining is a multibillion-dollar-a-year industry that, among other uses, allows pharmaceutical companies to pitch pricey brand-name drugs directly to individual doctors based on their prescribing habits.
Despite higher ticket prices and a sluggish economy, passenger traffic was up almost 4 percent at Newport News/Williamsburg International Airport during the first half of 2008. A total of 515,954 people flew through the airport during the past six months.
By Dickinson, James G THE FDA SAYS it has found at least two fundamental problems with data in a Harvard study, found in the New England Journal of Medicine, that showed drugs approved close to their Prescription Drug User Fee Act (PDUFA) deadline are more likely to have post- market safety problems than other drugs.
Older women will now have to wait longer to be vaccinated against cervical cancer. U.S. regulators denied Merck & Co.â€™s application to market Gardasil to women ages 27 through 45.
Researchers from M.D. Anderson Cancer Center in Houston reported Sunday that high doses of the arthritis medication Celebrex might prevent lung cancer in heavy smokers.
An appeals court in Texas reversed a $26.1 million verdict against drugmaker Merck & Co. Inc., finding no evidence that its popular painkiller Vioxx was responsible for the blood clot that triggered a fatal heart attack in Robert Ernst, the plaintiffâ€™s husband.